期刊文献+

血管性痴呆和阿尔茨海默病血清炎症因子、临床生化指标的变化 被引量:5

Changes of Serum Inflammatory Factors and Clinical Biochemical Indicators in Vascular Dementia and Alzheimer’s Disease
下载PDF
导出
摘要 目的:分析检测血管性痴呆(VD)和阿尔茨海默病(AD)血清炎症因子和临床生化指标的变化,为临床提供检测依据。方法:选取AD患者50例(AD组)和VD患者50例(VD组)以及收集同期健康老年人体检合格者50例作为正常对照组进行研究,检测三组血清炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、人白细胞介素-1α(IL-1α)和人白细胞介素-1β(IL-1β)]和生化指标[载脂蛋白E(apoE)、载脂蛋白B(apoB)、载脂蛋白A(apoA)、同型半胱氨酸(Hcy)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)],比较三组各指标的变化。结果:AD组和VD组TNF-α、IL-6及IL-1β均明显高于正常对照组,差异均有统计学意义(P<0.05),但AD组和VD组相比,差异均无统计学意义(P>0.05);三组IL-1α比较,差异均无统计学意义(P>0.05)。与正常对照组相比,AD组和VD组中LDL-C、TG和Hcy均明显增高,差异有统计学意义(P<0.05),HDL-C和apoA均明显降低,差异均有统计学意义(P<0.05);AD组和VD组TG相比,差异有统计学意义(P<0.05),但两组其他指标比较,差异均无统计学意义(P>0.05);三组TC、apoB和apoE比较,差异均无统计学意义(P>0.05)。结论:血清炎症因子和生化指标为VD和AD在临床上的诊断提供了一定的检测依据。 Objective:To analyze the changes of serum inflammatory factors and clinical biochemical markers in patients with vascular dementia(VD)and Alzheimer’s disease(AD),and providing evidence for clinical examination.Method:A total of 50 patients with AD(AD group)and 50 patients with VD(VD group),and 50 healthy old people who passed the physical examination in the same period were collected as the normal control group.The serum inflammatory factor[tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),human interleukin-1α(IL-1α)and human interleukin-1β(IL-1β)]and biochemical markers[Lipoprotein E(apoE),apolipoprotein B(apoB),apolipoprotein A(apoA),homocysteine(Hcy),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C),low-density lipoprotein cholesterol(LDL-C)and triglyceride(TG)]of three groups were detected,the changes in various indicators of three groups were compared.Result:The TNF-α,IL-6 and IL-1βin AD group and VD group were significantly higher than those in the normal control group,and the differences were statistically significant(P<0.05),but there were no significant differences between AD group and VD group(P>0.05).There were no significant differences in IL-1αamong three groups(P>0.05).Compared with the normal control group,LDL-C,TG and Hcy in AD group and VD group were significantly increased,the HDL-C and apoA were significantly lower,and the differences were statistically significant(P<0.05).TG of AD group and VD group compared,the difference was statistically significant(P<0.05),and the differences of other indexes in two groups were not statistically significant(P>0.05).There were no significant differences in TC,apoB and apoE among three groups(P>0.05).Conclusion:Serum inflammatory factors and biochemical indicators provide a basis for the clinical diagnosis of VD and AD.
作者 王静 杜红兴 WANG Jing;DU Hongxing(Shenyang Anning Hospital,Shenyang 110000,China)
机构地区 沈阳市安宁医院
出处 《中国医学创新》 CAS 2020年第9期40-44,共5页 Medical Innovation of China
关键词 血管性痴呆 阿尔茨海默病 血清炎症因子 生化指标 Vascular dementia Alzheimer’s disease Serum inflammatory factors Biochemical indicators
  • 相关文献

参考文献3

二级参考文献60

  • 1汪向东,王希林,马弘,等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.
  • 2Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord, 1999, 13 Suppl 3:115-123.
  • 3Malaguarnera M, Ferri R, Bella R, Alagona G, Carnemolla A, Pennisi G. Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease. Clin Chem Lab Med, 2004, 42:1032-1035.
  • 4Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr, 2004, 80:114-122.
  • 5World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992: 50-51.
  • 6McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS- ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 1984, 34:939-944.
  • 7Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, Erkinjuntti T. Comparison of different clinical criteria (DSM- BI, ADDTC, ICD- 10, NINDS-AIREN, DSM- IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke - Association Internationule pour la Recherche et l'Enseignement en Neuroseiences. Stroke, 2000, 31:2952-2957.
  • 8Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS- AIREN criteria. Dementia, 1994, 5(3/4):189-192.
  • 9Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wileock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement, 2015, 11:710-717.
  • 10Hayashi S, Sato N, Yamamoto A, Ikegame Y, Nakashima S, Ogihara T, Morishita R. Alzheimer disease-associated peptide, amyloid beta40, inhibits vascular regeneration with induction of endothelial autophagy. Arterioscler Thromb Vasc Biol, 2009, 29: 1909-1915.

共引文献435

同被引文献88

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部